Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Investissement Quebec

BioCentury | Jun 21, 2024
Finance

Venture Report: Syncona’s backs a pair of biotechs; Marea makes debut with $190M

Plus: Forbion’s new sustainability fund, and rounds for Elion, ashibio, NephroDI and Ability
BioCentury | May 30, 2024
Finance

Venture Report: Canadian VC Amplitude closes new fund; CinRx’s series C

Plus: Adcendo’s series A is again Denmark’s largest; VCs and foundations back Lucy
BioCentury | May 17, 2023
Regulation

May 17 Quick Takes: Intercept falls on negative tone of FDA briefing docs

Plus: Siren, Sania debut and updates from Aitia, PTC, enGene, Ardelyx, Akero and Satellos   
BioCentury | Mar 8, 2022
Emerging Company Profile

Congruence: identifying protein folding correctors 

Montreal-based newco is cataloging properties of misfolded proteins and building a virtual chemical library to screen for stabilizers
BioCentury | Feb 11, 2022
Deals

Feb. 10 Quick Takes: RA, Adjuvant ready Curevo to take on Shingrix with $60M A round

Seagen slides on guidance, and updates from Arkuda, Altesa, Aeglea, Congruence, 1859 and more
BioCentury | Jul 26, 2021
Finance

Seeking deals from all areas of U.S. and Canada, Lumira raises $220M fourth fund

About 80% will go to therapeutics, the remainder to medtech
BioCentury | Feb 11, 2013
Financial News

Medicago financial update

BioCentury | Jun 4, 2012
Finance

TVM's Canadian flavor

Teralys Capital, Eli Lilly go for new TVM biotech fund in Canada
BioCentury | Sep 28, 2009
Financial News

Aegera completes venture financing

BioCentury | May 23, 2005
Finance

Ebb & Flow

Items per page:
1 - 10 of 12